| Literature DB >> 29483291 |
Jikang Wu1, Anice Sabag-Daigle2, Mikayla A Borton3, Linnea F M Kop3, Blake E Szkoda1,4, Brooke L Deatherage Kaiser5, Stephen R Lindemann6, Ryan S Renslow6, Siwei Wei6, Carrie D Nicora6, Karl K Weitz6, Young-Mo Kim6, Joshua N Adkins6, Thomas O Metz6, Prosper Boyaka7, Venkat Gopalan1, Kelly C Wrighton3, Vicki H Wysocki8, Brian M M Ahmer9.
Abstract
Salmonella enterica elicits intestinal inflammation to gain access to nutrients. One of these nutrients is fructose-asparagine (F-Asn). The availability of F-Asn to Salmonella during infection is dependent upon Salmonella pathogenicity islands 1 and 2, which in turn are required to provoke inflammation. Here, we determined that F-Asn is present in mouse chow at approximately 400 pmol/mg (dry weight). F-Asn is also present in the intestinal tract of germfree mice at 2,700 pmol/mg (dry weight) and in the intestinal tract of conventional mice at 9 to 28 pmol/mg. These findings suggest that the mouse intestinal microbiota consumes F-Asn. We utilized heavy-labeled precursors of F-Asn to monitor its formation in the intestine, in the presence or absence of inflammation, and none was observed. Finally, we determined that some members of the class Clostridia encode F-Asn utilization pathways and that they are eliminated from highly inflamed Salmonella-infected mice. Collectively, our studies identify the source of F-Asn as the diet and that Salmonella-mediated inflammation is required to eliminate competitors and allow the pathogen nearly exclusive access to this nutrient.Entities:
Keywords: Amadori products; Clostridium; Maillard reaction; Salmonella; fructosamines; fructose-asparagine; gut inflammation; inflammation
Mesh:
Substances:
Year: 2018 PMID: 29483291 PMCID: PMC5913863 DOI: 10.1128/IAI.00945-17
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441